In the present study, we assessed the mRNA expression levels of ANP, BNP, and TNNT2 in cardiomyocytes to investigate the combined effects of SE and harmine in the treatment of cardiac hypertrophy. The gene discussed is NPPA; the disease is cardiac hypertrophy.